![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.orgShown: posts 1 to 4 of 4. This is the beginning of the thread.
Posted by Hugh on November 1, 2022, at 17:19:52
Researchers at the University of Calgary (U of C) are working on repurposing an antibiotic to improve the results of brain stimulation meant to defeat depression.
The antibiotic D-Cycloserine (DCS) helps magnetic stimulation (TMS) for people with major depressive disorder (MDD).
TMS is used to treat people who have treatment-resistant depression. However, it's not effective on everyone and scientists suspect this could be due to an important process in the brain for memory and learning.
"We think TMS works by driving the brain to adapt to stimulation through a process called synaptic plasticity," said Dr. Alexander McGirr, principal investigator on the study from U of C.
"One of the challenges, however, is that major depression is associated with reduced synaptic plasticity, and so TMS may be asking the depressed brain to adapt to stimulation in a way that it can not readily do. Adding D-Cycloserine to the TMS treatment appears to enhance TMS's ability to drive synaptic plasticity and treat depression."
The study examined participants for four weeks where they underwent TMS everyday. Also, half of them received DCS and the other half received a placebo.
The results were published in the JAMA Psychiatry and they show "almost 75 per cent of participants treated with DCS and TMS benefited, compared to only 30 per cent of those treated with TMS and a placebo."
Meanwhile, the gold standard Montgomery Asberg Depression Rating Scale was used to measure depressive symptom severity.
"The combination treatment seemed to have benefits beyond depressive symptoms. The participants in this study that received DCS and TMS also had greater improvements in their symptoms of anxiety and overall well-being," said study first author Jaeden Cole and a member of the McGirr lab.
Full article:
Posted by Hugh on November 2, 2022, at 10:28:59
In reply to Antibiotic greatly enhances efficacy of TMS, posted by Hugh on November 1, 2022, at 17:19:52
Drug: D-cycloserine
Daily oral D-cycloserine 100mg during the blinded phase (10 days).
Other Name: SeromycinDevice: Transcranial Magnetic Stimulator
Repetitive Transcranial magnetic stimulation (rTMS) will be delivered using a MagPro X100 device with B70 coil and the intermittent theta burst (iTBS) protocol to the left dorsolateral prefrontal cortex. Participants will receive daily treatments (Monday-Friday) over four weeks.Participants will orally ingest a capsule containing 100mg of the antibiotic d-cycloserine daily (Monday-Friday) for the first 2 weeks of rTMS treatment (10 sessions), followed by 2 weeks of rTMS without adjunctive medication.
Posted by TriedEveryMedication on November 7, 2022, at 20:39:30
In reply to Antibiotic greatly enhances efficacy of TMS, posted by Hugh on November 1, 2022, at 17:19:52
Interesting. DCS was also studied for fear extinction in exposure therapy.
Posted by Hugh on November 8, 2022, at 9:54:06
In reply to Re: Antibiotic greatly enhances efficacy of TMS, posted by TriedEveryMedication on November 7, 2022, at 20:39:30
It seems likely that D-cycloserine could make many therapies more effective, such as electro-convulsive therapy, neurofeedback, cognitive-behavioral therapy, EMDR, hypnotherapy, psychotherapy, acupuncture.
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.